Literature DB >> 8807211

Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design.

I M Feavers1, A J Fox, S Gray, D M Jones, M C Maiden.   

Abstract

The currently used serological subtyping scheme for the pathogen Neisseria meningitidis is not comprehensive, a proportion of isolates are reported as not subtypeable (NST), and few isolates are fully characterized with two subtypes for each strain. To establish the reasons for this and to assess the effectiveness of DNA-based subtyping schemes, dot blot hybridization and nucleotide sequence analyses were used to characterize the genes encoding antigenic variants of the meningococcal subtyping antigen, the PorA protein. A total of 233 strains, including 174 serologically NST and 59 partially or completely subtyped meningococcal strains, were surveyed. The NST isolates were chosen to be temporally and geographically representative of NST strains, isolated in England and Wales, and submitted to the Meningococcal Reference Unit in the period 1989 to 1991. The DNA-based analyses demonstrated that all of the strains examined possessed a porA gene. Some of these strains were serologically NST because of a lack of monoclonal antibodies against certain PorA epitopes; in other cases, strains expressed minor variants of known PorA epitopes that did not react with monoclonal antibodies in serological assays. Lack of expression remained a possible explanation for serological typing failure in some cases. These findings have important implications for epidemiological analysis and vaccine design and demonstrate the need for genetic characterization, rather than phenotypic characterization using monoclonal antibodies, for the identification of meningococcal strains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807211      PMCID: PMC170365          DOI: 10.1128/cdli.3.4.444-450.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  37 in total

1.  Serological relationships among meningococci.

Authors:  S E BRANHAM
Journal:  Bacteriol Rev       Date:  1953-09

Review 2.  Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

Authors:  C E Frasch; W D Zollinger; J T Poolman
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

Review 3.  Vaccines for prevention of meningococcal disease.

Authors:  C E Frasch
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA.

Authors:  H Abdillahi; J T Poolman
Journal:  Microb Pathog       Date:  1988-01       Impact factor: 3.738

Review 5.  Virulence functions and antigen variation in pathogenic Neisseriae.

Authors:  T F Meyer; M Frosch; C P Gibbs; R Haas; R Halter; J Pohlner; J P van Putten
Journal:  Antonie Van Leeuwenhoek       Date:  1988       Impact factor: 2.271

6.  Five structural classes of major outer membrane proteins in Neisseria meningitidis.

Authors:  C M Tsai; C E Frasch; L F Mocca
Journal:  J Bacteriol       Date:  1981-04       Impact factor: 3.490

7.  Rapid fermentation confirmation of Neisseria gonorrhoeae.

Authors:  D S Kellogg; E M Turner
Journal:  Appl Microbiol       Date:  1973-04

Review 8.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

9.  The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica.

Authors:  K A Cartwright; J M Stuart; D M Jones; N D Noah
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

10.  Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.

Authors:  B McGuinness; A K Barlow; I N Clarke; J E Farley; A Anilionis; J T Poolman; J E Heckels
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

View more
  21 in total

1.  Neisseria meningitidis subtype nomenclature.

Authors:  M C Maiden; J Russell; J Suker; I M Feavers
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Sequence variation in the porA gene of a clone of Neisseria meningitidis during epidemic spread.

Authors:  J Jelfs; R Munro; E Wedege; D A Caugant
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

3.  Direct and rapid identification and genogrouping of meningococci and porA amplification by LightCycler PCR.

Authors:  Paula Mölling; Susanne Jacobsson; Anders Bäckman; Per Olcén
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 4.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system.

Authors:  C T Sacchi; A P Lemos; A M Whitney; C A Solari; M E Brandt; C E Melles; C E Frasch; L W Mayer
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

Review 6.  Molecular techniques for the investigation of meningococcal disease epidemiology.

Authors:  M C Maiden; M Frosch
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

7.  Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.

Authors:  C T Sacchi; A P Lemos; T Popovic; J C De Morais; A M Whitney; C E Melles; L M Brondi; L M Monteiro; M V Paiva; C A Solari; L W Mayer
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

8.  T-cell-stimulating protein A elicits immune responses during meningococcal carriage and human disease.

Authors:  Karen Robinson; Karl G Wooldridge; Damien B Wells; Amal Hasan; Ian Todd; Adrian Robins; Richard James; Dlawer A A Ala'Aldeen
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

9.  Redesignation of a purported P1.15 subtype-specific meningococcal monoclonal antibody as a P1.19-specific reagent.

Authors:  E Wedege; D A Caugant; A Musacchio; N B Saunders; W D Zollinger
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

10.  Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature.

Authors:  C T Sacchi; A P Lemos; M E Brandt; A M Whitney; C E Melles; C A Solari; C E Frasch; L W Mayer
Journal:  Clin Diagn Lab Immunol       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.